Clinical Topics & News


Safety and Efficacy of Halobetasol Propionate Lotion 0.01% in the Treatment of Moderate to Severe Plaque Psoriasis: A Pooled Analysis of 2 Phase 3 Studies

Potent topical corticosteroids are the mainstay of psoriasis treatment, but safety concerns have limited use to 2 to 4 weeks. This study...


Psoriasis Risk Factors and Triggers

Numerous factors contribute to the onset and exacerbation of psoriasis. Genetic risk factors include HLA-Cw6 and mutations in the caspase...


Biologic Therapy in Psoriasis: Navigating the Options

Psoriasis is a T cell–mediated inflammatory disease associated with comorbidities impacting the overall health and quality of life of those...


Food for Thought

This special issue is dedicated to resident education on psoriasis. With that in mind, we hope to address many topics of...